Covid19
Showing NaN - NaN of 11
Covid19 Trial in Bronx, Long Island City (Onsite Point-of-care)
Recruiting
- Covid19
- Onsite Point-of-care
-
Bronx, New York
- +1 more
Jan 7, 2023
Covid19 Trial in Brazil, United States (Remdesivir, Remdesivir Placebo, Aviptadil)
Completed
- Covid19
- Remdesivir
- +4 more
-
Tucson, Arizona
- +39 more
Dec 16, 2022
COVID-19 Citizen Science Expansion Project
Enrolling by invitation
- Covid19
-
Sacramento, California
- +8 more
Sep 30, 2022
Parenting, Covid19 Trial in Bronx (CARE Program and Valera Application with care manager functionality, Valera Application with
Recruiting
- Parenting
- Covid19
- CARE Program and Valera Application with care manager functionality
- +4 more
-
Bronx, New YorkPRIME
Aug 10, 2022
Covid19 Trial in South Africa, United States (Part A: Upamostat 200 mg, Part A: Upamostat 400 mg, Part A and B: Placebo)
Suspended
- Covid19
- Part A: Upamostat 200 mg
- +3 more
-
Cutler Bay, Florida
- +16 more
Aug 2, 2022
Covid19 Trial in United States (Apixaban 2.5 MG, Placebo)
Active, not recruiting
- Covid19
- Apixaban 2.5 MG
- Placebo
-
Phoenix, Arizona
- +120 more
Jul 1, 2022
Covid19 Trial in Worldwide (theraputic heparin, prophylactic heparin, P2Y12)
Recruiting
- Covid19
- theraputic heparin
- +4 more
-
Birmingham, Alabama
- +101 more
Jun 28, 2022
Mucormycosis in COVID-19
Completed
- Covid19
- +3 more
-
Bronx, New YorkMontefiore Medical Center
Apr 29, 2022
Covid19 Trial in Worldwide (Sotrovimab (Gen1), Sotrovimab (Gen2))
Active, not recruiting
- Covid19
- Sotrovimab (Gen1)
- Sotrovimab (Gen2)
-
Anniston, Alabama
- +30 more
Feb 4, 2022
Covid19, SARS (Severe Acute Respiratory Syndrome), SARS-CoV Infection Trial in New Zealand, United States (biological, drug,
Unknown status
- Covid19
- +3 more
- Biological: oral polio vaccine
- +5 more
-
Los Angeles, California
- +9 more
Sep 5, 2020